BISPOrPhyrIn COnneCteD By PyrImIDIne: SyntheSIS AnD PhOtOPhySICAl PrOPertIeS
883
Me4Si): δH, ppm 10.33 (d, 4H, J = 4.5 Hz, H-2, 18), 9.88
the fondation Pierre-Gilles de Gennes for a postdoctoral
fellowship.
(s, 1H, H-2pyrim), 9.23 (d, 4H, J = 4.5 Hz, H-3, 17), 9.05
(d, 4H, J = 4.5 Hz, H-7, 13/8, 12), 9.02 (d, 4H, J = 4.5 Hz,
H-7, 13/8, 12), 8.98 (s, 1H, H-5pyrim), 8.36–8.34 (m, 12H,
H-Ph), 7.81–7.76 (m, 18H, H-Ph). MS (MALDI-TOF):
m/z 1325.25 (C84H49N10Zn2, [M + H]+, requires 1325.27).
Anal. calcd. for C84H48N10Zn2 + 11 H2O: C 66.10, H 4.62,
N 9.18. Found C, 66.06 H, 4.53 N, 8.95.
REFERENCES
1. a) Dougherty TJ, Gomer CJ, Henderson BW, Jori
G, Kessel D, Korbelik M, Moan J and Peng Q. J.
Nat. Canc. Inst. 1998; 90: 889–905. b) Chemical
Aspects of Photodynamic Therapy, Bonnet R. (Ed.)
Gordon and Breach Science Publishers: Amster-
dam, 2000. c) MacDonald IJ and Dougherty TJ. J.
Porphyrins Phthalocyanines 2001; 5: 105–129. d)
Dolmans DEJGJ, Fukumura D and Jain RK. Nat.
Rev. 2003; 3: 380–386. e) Robertson CA, Hawkins
Evans D and Abrahamse H. J. Photochem. Photo-
biol., B 2009; 96: 1–8.
2. Bonnett R. Chem. Soc. Rev. 1995; 24: 19–33.
3. a) Electrooptics Handbook, Waynant RW and Edi-
ger MN. (Eds.) McGraw-Hill: New York, 1993;
Chapter 24. b) Tromberg BJ, Shah N, Lanning R,
Cerussi A, Espinoza J, Pham T, Svaasand L and
Butler J. Neoplasia 2000; 2: 26.
[5-ethynyl-(10,15,20-triphenyl)porphyrinato
Zn(II)]-2′-(methylthio)pyrimidine 8. Dark green solid
(43 mg, 46%). UV-vis (CH2Cl2): λmax, nm (ε, L.mmol-1.
1
cm-1) 440 (610), 568 (19.7), 619 (28.2). H NMR (300
MHz, CDCl3, Me4Si): δH, ppm 9.76 (d, 2H, J = 4.8 Hz,
H-2, 18), 9.00 (d, 2H, J = 4.8 Hz, H-3, 17), 8.86 (d, 2H,
J = 4.8 Hz, H-7, 13/8, 12), 8.83 (d, 2H, J = 4.8 Hz, H-7,
13/8, 12), 8.46 (d, 1H, J = 5 Hz, H-6pyrim), 8.20–8.15 (m,
6H, H-Ph), 7.78–7.73 (m, 9H, H-Ph), 7.47 (d, 1H, J =
5 Hz, H-5pyrim), 2.67 (s, 3H, SMe). MS (MALDI-TOF):
m/z 748.14 (calcd. for [M]+ 748.14). Anal. calcd. for
C45H28N6SZn + 8 H2O: C 60.43, H 4.96, N 9.40, S 3.59.
Found C, 60.81 H, 5.25 N, 9.51, S 3.43.
[5-ethynyl-(10,15,20-triphenyl)porphyrinato
Zn(II)]-6′-(iodo)pyrimidine 9. Dark green solid (34 mg,
33%). UV-vis (CH2Cl2): λmax, nm (ε, L.mmol-1.cm-1) 444
4. a) Goyan RL and Cramb DT. Photochem. Photobiol.
2000; 72: 821–827. b) Dichtel WR, Serin JM, Edder
C, Frechet JM, Matuszewski M, Tan LS, Ohulchan-
skyy TY and Prassad PN. J. Am. Chem. Soc. 2004;
126: 5380–5381.
1
(660), 568 (24), 625 (43). H NMR (300 MHz, CDCl3,
Me4Si): δH, ppm 9.32 (d, 2H, J = 4.8 Hz, H-2, 18), 8.94
(d, 2H, J = 4.8 Hz, H-3, 17), 8.85 (d, 2H, J = 4.8 Hz,
H-7, 13/8, 12), 8.81 (d, 2H, J = 4.8 Hz, H-7, 13/8, 12),
8.20–8.18 (m, 7H, H-Ph + H-2pyrim), 7.90 (s, 1H, H-5pyrim),
7.80–7.76 (m, 9H, H-Ph). 13C NMR (75 MHz, CDCl3,
Me4Si): δC, ppm 170.0 (C-2pyrim), 154.0 (C-4pyrim), 153.0–
149.6 (C-1, 19/4, 16/6, 14/9, 11), 142.73 (C-1Ph), 142.67
(C-1Ph), 134.4 (C-Ph), 134.3 (C-Ph), 131.6–131.1, (C-2,
3, 7, 8, 12, 13, 17, 18), 128.2 (C-Ph), 128.1 (C-Ph), 127.5
(C-5pyrim), 126.5 (C-Ph), 126.4 (C-Ph), 122.6 (C-5/15)
121.9 (C-10), 106.4 (C-20), 103.4 (C-alkyne), 97.1
(C-alkyne). MS (MALDI-TOF): m/z 828.05 (calcd. for
[M]+ 828.06).
5. a) Karotki A, Drobizhev M, Dzenis Y, Taylor PN,
Anderson HL and Rebane A. Phys. Chem. Chem.
Phys. 2004; 6: 7–10. b) Frampton MJ, Akdas H,
Cowley AR, Rogers JE, Slagle JE, Fleitz PA, Dro-
bizhev M, Rebane A and Anderson HL. Org. Lett.
2005; 7: 5365–5368. c) He GS, Tan LS, Zheng Q
and Prasad PN. Chem. Rev. 2008; 108: 1245–1330.
6. a) Arnold DP, Johnson AW and Mahendran M.
J. Chem. Soc. Perkin Trans. 1 1978; 366–370. b)
Arnold DP and James DA. J. Org. Chem. 1997;
62: 3460–3469. c) Anderson HL. Chem. Commun.
1999; 2323–2330. d) Balaz M, Collins HA, Dahlst-
edt E and Anderson HL. Org. Biomol. Chem. 2009;
7: 874–888. e) Kuimova MK, Collins HA, Balaz M,
Dahlstedt E, Levitt JA, Sergent N, Suhling K, Drobi-
zhev M, Makarov NS, Rebane A, Anderson HL and
Phillips D. Org. Biomol. Chem. 2009; 7: 889–904.
f) Collins HA, Khurana M, Moriyama EH, Mari-
ampillai A, Dahlstedt E, Balaz M, Kuimova MK,
Drobizhev M, Yang VXD, Phillips D, Rebane A,
Wilson BC and Anderson HL. Nat. Photonics 2008;
2: 420–424.
CONCLUSION
In this contribution, we have successfully synthesized
a V-shaped bisporphyrin conjugate using a meta-difunc-
tionalized pyrimidine core and two meso-ethynylporphy-
rin arms. Computational and photophysical studies show
that this structure is a promising D-π-A-π-D fluorophore.
Such porphyrin conjugates can afford valuable advan-
tages in applications of TPA materials such as in photo-
dynamic therapy and imaging of biological entities.
7. a) Arnold DP and Nitschinsk LJ. Tetrahedron Lett.
1993; 34: 693–696. b) Arnold DP and James DA. J.
Org. Chem. 1997; 62: 3460–3469.
8. Arnold DP, James DA, Kennard CHL and Smith G.
J. Chem. Soc. Chem. Commun. 1994; 2131–2132.
9. Taylor PN, Wylie AP, Huuskonen J and Anderson
HL. Angew. Chem. Int. Ed. 1998; 37: 986–989.
Acknowledgements
We thank Mr. Jean Bernard for TPA measurements,
Mr Vincent Guérineau for MALDI-TOF analysis and the
center of computing services of the Paris-Sud IT depart-
ment. This work has been supported by INCa (2009–1-
RT-08-IC-1) and the French association “Rétinostop”
Copyright © 2010 World Scientific Publishing Company
J. Porphyrins Phthalocyanines 2010; 14: 883–884